Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behavior, and Therapy by Nurit Horesh, Netanel A. Horowitz

Get full text

Development of multifocal leukoencephalopathy in patients undergoing allogeneic stem cell transplantation—can preemptive detection of John Cunningham virus be useful? by Irit Avivi, Talya Wittmann, Israel Henig, Zipora Kra-Oz, Moran Szwarcwort Cohen, Tsila Zuckerman, Netanel A. Horowitz, Noam Benyamini

Get full text

Revisiting SARS-CoV-2 environmental contamination by patients with COVID-19: The Omicron variant does not differ from previous strains by Itai Glinert, Amir Ben-Shmuel, Moran Szwartcwort-Cohen, Adi Beth-din, Orly Laskar, Moria Barlev-Gross, Sharon Melamed, Noga Arbell, Haim Levy, Netanel A Horowitz, Shay Weiss

Get full text

Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg? by Vladimir Vainstein, Batia Avni, Sigal Grisariu, Shlomit Kfir-Erenfeld, Nathalie Asherie, Boaz Nachmias, Shlomtzion Auman, Revital Saban, Eran Zimran, Miri Assayag, Kalman Filanovsky, Netanel A. Horowitz, Eyal Lebel, Adir Shaulov, Michal Gur, Chaggai Rosenbluh, Svetlana Krichevsky, Polina Stepensky, Moshe E. Gatt

Get full text

Continuous Remote Patient Monitoring Shows Early Cardiovascular Changes in COVID-19 Patients by Arik Eisenkraft, Yasmin Maor, Keren Constantini, Nir Goldstein, Dean Nachman, Ran Levy, Michael Halberthal, Netanel A. Horowitz, Ron Golan, Elli Rosenberg, Eitan Lavon, Ornit Cohen, Guy Shapira, Noam Shomron, Arik Ben Ishay, Efrat Sand, Roei Merin, Meir Fons, Romi Littman, Yftach Gepner

Get full text

A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma by Graham P. Collins, Toby A. Eyre, Debora Schmitz-Rohmer, William Townsend, Rakesh Popat, Lisa Giulino-Roth, Paul A. Fields, Fatime Krasniqi, Carole Soussain, Anastasios Stathis, Nebojsa Andjelkovic, David Cunningham, Danijela Mandic, Sinisa Radulovic, Ivan Tijanic, Netanel A. Horowitz, Sabira Kurtovic, Elisabeth Schorb, Christian Schmidt, Saša Dimitrijević, Martin Dreyling

Get full text

An international multicenter study comparing COVID‐19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab by Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira, Ana Belkin, Ofir Deri, Yonatan Oster, Shadi Zahran, Ehud Horwitz, Netanel A. Horowitz, Hazim Khatib, Marjorie Vieira Batista, Anita Cassoli Cortez, Tal Brosh‐Nissimov, Yafit Segman, Linor Ishay, Regev Cohen, Alaa Atamna, Amy Spallone, Roy F. Chemaly, Juan Carlos Ramos‐Ramos, Michal Chowers, Evgeny Rogozin, Noga Carmi Oren, Şiran Keske, Orit Wolfovitz Barchad, Lior Nesher, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV)

Get full text